Elon Musk’s SpaceX (NASDAQ: SPCX) last week issued its prospectus for an initial public offering (IPO) of shares, which would cement Mr Musk’s status as the richest person on Earth and value the company at up to US$2 trillion.

The prospectus for the first time sheds light on the financials of the company’s three divisions – the SpaceX rocket division, the Starlink satellite internet division, and the artificial intelligence division.

Lofty ambitions

Of the three, only Starlink turns a profit at the moment, but early on in the prospectus, it is clear that what you are buying into is as much about a very optimistic view of the future – and the future of the company – based around interplanetary travel, as it is about financial returns.

Naturally, these are meant to flow as the company achieves its mission, which it sets out early on, as such:

Our mission is to build the systems and technologies necessary to make life multiplanetary, to understand the true nature of the universe, and to extend the light of consciousness to the stars. To do this, we have formed the most ambitious, vertically integrated innovation engine on (and off) Earth with unmatched capabilities to rapidly manufacture and launch space-based communications that connect the world, to harness the Sun to power a truth-seeking artificial intelligence that advances scientific discovery, and ultimately to build a base on the Moon and cities on other planets.

SpaceX says, “We believe that space represents the largest economic frontier in human history”, and suggests that they will be building AI infrastructure in space, powered by the “virtually limitless” power of the sun, for the benefit of mankind.

While the company’s ambitions are lofty, it’s currently still burning money, making a US$2.59 billion loss on revenue of US$18.7 billion in 2025.

For the first three months of 2026, the Space division lost US$662 million, the AI division lost US$2.47 billion, and the connectivity division made a profit of US$1.19 billion.

So, at this point, investors will be very much buying into a growth story, rather than a profitable business.

How to buy into the vision

If this is something that you find compelling, the good news is that Australian brokers are likely to be able to offer shares in the SpaceX IPO.

As the prospectus says:

The public offering in Australia will be made pursuant to a separate prospectus which complies with the requirements of the Corporations Act and will be lodged with the Australian Securities and Investments Commission.

Broker CommSec has written to its customers this week, saying the IPO is “expected” to include an Australian retail offer and that it will be the lead Australian retail broker for the IPO.

CommSec said the shares will not be listed on the ASX, and its customers will need an international shares account.

It will also be possible for Australians with an international trading account to buy and sell shares once trading begins on the NASDAQ exchange, expected around June 12.

The post How Australians can buy SpaceX shares in the IPO appeared first on The Motley Fool Australia.

More reading

• Virgin Australia, Qantas shares jump 8% higher this week. Are the ASX airline stocks a buy, sell or hold?
• Down 40%+! I’d buy CSL and these ASX shares while investors are still cautious
• Could this ASX ETF be the easiest way to invest in global quality?
• Buying Santos shares? Here’s how the company aims to cut spending and lift production
• Why are this ASX data centre company’s shares down more than 6%

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The rise of GLP-1 obesity drugs like Ozempic and Wegovy has been one of the most covered investment stories of the past two years.

For ResMed Inc (ASX: RMD), the debate has centred on a single question: If millions of people lose weight and no longer suffer from sleep apnea, what happens to demand for CPAP machines?

It is a fair question, and for most of 2025, the market answered it by selling ResMed shares aggressively, at one point sending them to a multi-year low as investors priced in an existential threat to the company’s core business.

Today, the evidence suggests that fear was significantly overstated, and that GLP-1 drugs may actually be one of the most powerful demand drivers ResMed has encountered in years.

Why the fear made sense initially

The bear case was not irrational.

Between 70% and 90% of obstructive sleep apnea cases are driven by obesity, meaning a drug that reliably reduces body weight could logically reduce the addressable market for CPAP devices over time.

That concern became more acute when Eli Lilly‘s GLP-1 drug Zepbound received FDA approval to treat obstructive sleep apnea directly, without requiring a CPAP machine.

This marked the first time a pharmaceutical had been approved as an alternative to device therapy for the condition.

ResMed shares fell sharply on that news, and the stock spent much of 2025 in what analysts described as the penalty box, maintained on watch lists but held back from buy recommendations pending clarity on whether GLP-1 adoption would materially erode device demand.

But the real-world data tells a different story

The most important piece of evidence came from ResMed’s own Q3 FY 2026 earnings call, where CEO Mick Farrell presented new data drawn from a cohort of 1.7 million de-identified patients.

The finding was striking.

PAP patients who subsequently start GLP-1 therapy show higher PAP adherence rates than patients on PAP alone, with two-year resupply rates 5.1% higher and three-year resupply rates 6.2% higher.

In other words, patients who take GLP-1 drugs while using CPAP therapy are more likely to keep using their devices, not less. Farrell went further, stating directly on the call:

We believe GLP-1s are truly a megatrend, and a once-in-a-generation demand-gen opportunity for ResMed Inc. Both GLP-1s and wearables alike are driving more patients to talk with their doctors and ultimately, we believe this will lead to more patients coming into the ResMed Inc. ecosystem.

Why GLP-1s are actually driving more patients to ResMed

As GLP-1 drugs become mainstream and patients visit doctors more frequently to manage their weight, they are also being screened for obesity-related conditions they may not have known they had, including sleep apnea.

According to ResMed, approximately one billion people worldwide are affected by sleep apnea, the vast majority of whom remain undiagnosed.

GLP-1 adoption is bringing millions of those undiagnosed patients into the healthcare system for the first time, and a meaningful proportion of them are receiving sleep apnea diagnoses and CPAP prescriptions as a result.

Furthermore, a meta-analysis published in GeroScience showed that individuals with sleep apnea have a 33% higher risk of developing dementia, and that sleep apnea was associated with a 45% increased risk of Alzheimer’s disease.

That evidence is motivating payers, health systems, and physicians to screen and treat sleep apnea more aggressively than ever before.

The financial performance backs it up

ResMed’s most recent quarterly results leave little doubt about the health of the underlying business.

In Q3 FY 2026, the company delivered revenue of US$1.29 billion, up 11% year on year, with operating income rising 22% and gross margins improving to 58.9%.

The software and services segment, which manages patient data and remote monitoring across more than 23 billion nights of sleep data, grew at a double-digit rate and now generates more than US$200 million per quarter.

ResMed shares remain down in 2026, a hangover from the GLP-1 fear trade that has not yet fully unwound.

Foolish Takeaway

ResMed was sold down on a fear that turned out to be wrong, or at least far less threatening than investors assumed.

The company’s own data now shows that GLP-1 adoption is increasing CPAP adherence, bringing more undiagnosed patients into the healthcare system, and creating what management has described as a once-in-a-generation demand opportunity.

For investors who can look past a year of negative sentiment and focus on what the numbers actually say, ResMed looks like one of the more interesting large-cap healthcare opportunities on the ASX today.

The post The global obesity drug boom could be bigger than investors realise for this ASX stock appeared first on The Motley Fool Australia.

More reading

• I would buy these world-class ASX shares for an SMSF
• How to start investing in ASX shares in 2026
• I’d listen to Warren Buffett and load up on cheap ASX shares
• I’d buy these 3 ASX shares before the next market rally
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Mark Verhoeven has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Eli Lilly and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

BHP Group Ltd (ASX: BHP) shares are in the spotlight this week.

The miner’s shares are down 0.2% at $60 a piece in early morning trade on Tuesday. The stock is now 31% higher for the year to date and 56% higher than 12 months ago.

For context, the S&P/ASX 200 Index (ASX: XJO) has tumbled 0.49% this morning, with over half of the companies in the index falling into the red.

Why are BHP shares catching attention this week?

BHP shares hit a fresh record high on Friday last week after investors rotated back into diversified miners after the price of copper surged close to a multi-year high.

According to Trading Economics, copper futures climbed to around US$6.4 per pound on Monday, reaching their highest level in more than a week. Stronger investor sentiment comes off the back of signs that the US and Iran were moving closer to a deal that could reopen the Strait of Hormuz.

At the same time, the miner’s climate policy is generating headlines this week. The mining giant has reportedly delayed billions of dollars in Pilbara decarbonization projects, according to the Guardian. 

In 2019, the miner pledged to reduce emissions from its operations, largely from energy and diesel use at its mines, by 30% by 2030.

It also sought to curtail indirect emissions – from the use of its iron ore and coal by others – which, at that stage, were equivalent to pollution from roughly 126m cars.

But, a leaked document outlines the company’s latest plans to decarbonise its network of Pilbara mines, power plants, trains, and diesel truck fleets that make up its Western Australian iron ore division, the Guardian explains. 

“The urgency for BHP to source renewables had diminished”, it said. BHP was now claiming the plan it had devised to hit net zero in the Pilbara by 2050 had a “low probability of success,” the Guardian reports.

What’s next for BHP shares?

It looks like BHP shares have now reached a ceiling. 

Analysts are mostly reserved about the outlook for the mining giant over the next 12 months.

Market Index brokers have a hold rating on BHP shares and tip a 2% downside to an average target price of $58.77.

The data is similar on TradingView. Out of 19 analysts, 14 have a hold rating on the mining stock. Another four rate the shares as a strong buy, and 1 rates them as a sell.

The average $57.36 target price implies a potential 4% downside at the time of writing. But some think the shares could crash 34% to $39.67, and others think the stock can still climb another 15% to $69.03 within the next 12 months.

The post Why is everyone talking about BHP shares this week? appeared first on The Motley Fool Australia.

More reading

• Is now a good time to buy and hold BHP shares?
• Why a weak US dollar could be the best thing that happens to ASX resource stocks in 2026
• Invested $10,000 in Rio Tinto, Fortescue or BHP shares 5 years ago? Guess which one has gained the most
• Thinking about dividend yields? Here’s how much the top 10 ASX 200 shares pay
• How big will the BHP dividend be in 2027?

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BHP Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Kogan.com Ltd (ASX: KGN) shares are having a strong session on Tuesday.

In morning trade, the ASX All Ords share is up 20% to $4.14.

This compares very favourably to the performance of the All Ordinaries index (ASX: XAO), which is down 0.55% at the time of writing.

Why is this ASX All Ords share rocketing today?

The online retailer’s shares are rallying today after it released a trading update before the market open.

According to the release, Kogan has recorded strong sales growth, expanding operating leverage, and profitability over the 10 months ended 30 April.

The core Kogan business achieved gross sales growth of 18.2%, revenue growth of 18.1%, and gross profit growth of 19.5% during the period.

The ASX All Ords share notes that this performance was driven by growth in active customers, increased customer engagement, and continued expansion in platform-based sales.

In addition, the business benefitted from strategic marketing investment and operational cost management, which is contributing to strong operating leverage.

As a result, Kogan segment adjusted EBITDA and adjusted EBIT increased by 32% and 43.2%, respectively, over the prior corresponding period.

Another positive is that the Mighty Ape business continued to make significant progress to profitability. This was driven by aligning its strategy to the wider group.

It notes that momentum accelerated in the four months to 30 April, with its gross margin increasing 8.4 percentage points to 37.8% and adjusted EBITDA losses reducing by 52.8% against the prior corresponding period.

The company stated:

The Company delivered a Group Adjusted EBITDA margin of 8.6%, towards the upper end of previously provided FY26 guidance, which includes the impact of the turnaround of Mighty Ape. This performance was driven by strong profitability within Kogan.com, which achieved Adjusted EBITDA margin of 11.5%, together with materially improved performance at Mighty Ape in the most recent four months to 30 April 2026.

Group results look strong

In light of the above, for the 10 months, total gross sales were up 13.2% to $875.6 million.

Group active customers increased by 4% to 3.5 million, with Kogan active customers increasing by 9%.

The company’s gross profit increased by 11.1% to $177.9 million after its gross margin improved by 1.9 percentage points to 41%.

This ultimately led to group adjusted EBITDA increasing 17.4% to $37.5 million and group adjusted EBIT increasing 25.4% to $26.9 million.

This is quite a turnaround for the ecommerce company after a challenging period.

Following today’s gain, Kogan’s shares are now up over 40% from the 52-week low they reached back in November.

The post Guess which ASX All Ords share is rocketing 20% on big news appeared first on The Motley Fool Australia.

More reading

• Buy, hold, sell: Bega Cheese, Kogan, Macquarie shares

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Kogan.com. The Motley Fool Australia has recommended Kogan.com. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Treasury Wine Estates Ltd (ASX: TWE) shares are in the red on Tuesday after investors were handed another leadership update.

At the time of writing, the Treasury Wine share price is down 2.82% to $4.48.

The move adds to a rough period for shareholders. The Penfolds owner is now down around 15% in 2026 and 46% over the past year.

The latest pressure comes as the company prepares for a major change to how the business is run.

CFO exit brought forward

According to the release, Boxer’s retirement has been moved forward by a month.

His departure was announced in March and had been scheduled for 30 September. This was one day before Treasury Wine’s new regional operating model takes effect on 1 October.

He is now set to leave on 30 June, after six years with the company.

Deputy CFO Justin Pipito will reportedly become interim CFO and strategy officer from 1 June.

Treasury Wine did not give a reason for the earlier exit date.

A business in the middle of a reset

Treasury Wine is also working through a broader restructure after a difficult stretch in key markets.

The company announced in April that it would shift to a regional operating model across the Americas, Australia and New Zealand and Europe, Greater China, and emerging markets.

The restructure also means Penfolds will no longer sit as a stand-alone division.

It is a significant change for the business, given Penfolds has long been Treasury Wine’s flagship luxury wine brand.

Management said the new structure is designed to improve efficiency and accountability across each region.

The update landed well with the market at the time. Treasury Wine shares rose 16.54% after the company reaffirmed guidance and pointed to stronger depletions in China and the United States.

Depletions refer to shipments from distributors and wholesalers to customers such as retailers, bottle shops, and restaurants. They can give a cleaner read on underlying demand than shipments into warehouses.

Why the share price is still under pressure

Today’s share price fall shows the market still needs more convincing.

Treasury Wine is dealing with softer demand, pressure in the United States, and a difficult global wine market.

It is also trying to rebuild momentum in China after several disrupted years.

There have been some better signs. In April, Treasury Wine said Penfolds depletions rose 40% in China over the Chinese New Year period.

Overall US market depletions were also up 9.1% on the previous corresponding period.

But after a 45% fall in the share price over the past year, the market still wants stronger proof that the reset is working.

The post Treasury Wine shares slide as another leadership change hits sentiment appeared first on The Motley Fool Australia.

More reading

• These are the 10 most shorted ASX shares
• ASX 200 consumer staples shares outperformed again last week
• 3 ASX 200 shares I’d buy before the market wakes up
• Down 50%: Why this ASX 200 share could be a smart buy before confidence returns
• 3 top ASX dividend shares to buy with $3,000

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Treasury Wine Estates. The Motley Fool Australia has positions in and has recommended Treasury Wine Estates. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The interest rate on term deposits has risen this year, thanks to the higher RBA interest rate. But I still rate ASX dividend shares as better investments for people who want to generate passive income.

There are two factors that make me want to choose businesses over term deposits. They can offer a higher yield, and they can deliver growth. Both the payout and share price can grow over time.

I’m calling the below ASX dividend shares compelling ideas to buy today.

Rural Funds Group (ASX: RFF)

Rural Funds is a real estate investment trust (REIT) that owns farmland across Australia in different states and climate conditions.

The REIT owns a few different types of farms, including almonds, cattle, vineyards, macadamias and cropping. I like the diversification here because it reduces the risk of being overly exposed to one type of farm and gives it more industry areas to look for opportunities.

Rural Funds has a solid distribution yield, currently paying 11.73 cents per unit annually. That translates into a forward distribution yield of 5.9%.

Higher interest rates are a headwind for Rural Funds in the short term, but the business has steadily growing rental income thanks to fixed annual increases for some farms and inflation-linked increases at others.

It looks like a bargain to me because of the discount between the unit (share) price on the ASX and the latest net asset value (NAV). The adjusted NAV was $3.10 as of 31 December 2025, so it’s currently trading at a discount of around 36% to that figure, which is a very attractive discount in my books.

WCM Global Growth Ltd (ASX: WQG)

The other ASX dividend share I want to highlight that’s more attractive than a term deposit is this listed investment company (LIC), which invests in a portfolio of quality global shares.

The idea is that the investment team look for businesses with expanding economic moats (or improving competitive advantages). Companies that become steadily stronger are more likely to deliver pleasing profit growth and shareholder returns, in my opinion.

Another feature that the WCM investment team looks for is a corporate culture that helps improve the economic moat. WCM has specific aspects it looks for, as well as questions for management, that help determine whether the corporate culture is positive.

The LIC’s portfolio has delivered a net return (after fees) of 15.4% since inception in June 2017, helping it fund both a growing dividend and capital growth of the share price.

It is increasing its quarterly dividend every quarter, which is pleasing consistency for shareholders.

The next four quarterly dividends to be officially declared are expected to amount to 9.59 cents per share, which translates into a grossed-up dividend yield of 7.3%, including franking credits.

This ASX dividend share is also trading at a small discount to its net tangible assets (NTA), so I think it’s a good time to invest.

The post Forget term deposits! I’d buy these ASX dividend shares instead appeared first on The Motley Fool Australia.

More reading

• Buy these ASX dividend shares with 6%+ yields
• These ASX dividend shares keep giving investors a pay rise
• How much is needed in superannuation to target a $7,500 monthly passive income?
• How to build a $52,000 annual passive income
• 3 excellent ASX dividend shares for income investors to buy in May

Motley Fool contributor Tristan Harrison has positions in Rural Funds Group and Wcm Global Growth. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Rural Funds Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The All Ordinaries Index (ASX: XAO) is down 0.6% today, but don’t blame this ASX All Ords silver share.

The outperforming stock in question is Silver Mines Ltd (ASX: SVL).

Silver Mines shares closed yesterday trading for 15.5 cents. In morning trade on Tuesday, shares are changing hands for 16.3 cents apiece, up 4.8%.

This sees the Silver Mines share price up an impressive 63.9% over the last 12 months, racing ahead of the 3.2% one-year gains posted by the All Ords.

Here’s what’s grabbing investor interest again today.

ASX All Ords silver share jumps on land purchase

Silver Mines shares are charging higher after the miner announced that its wholly owned subsidiary, Bowdens Silver, has inked a binding agreement to acquire a parcel of freehold land. The agreement also includes associated water entitlements.

The newly acquired land is strategically located next to Silver Mines’ flagship Bowdens Silver Project, located in New South Wales.

The ASX All Ords silver share noted that, on completion of the latest acquisition, it will own some 3,345 hectares of freehold land. Taken together with its existing leases and land access agreements, this covers the entire Bowdens Silver Project area along with “a substantial surrounding buffer area”.

Silver Mines will pay $12.5 million in cash for the new freehold land parcel, with $1.76 million already having been paid to vendors. The miner will dip into its existing cash reserves to fund the purchase. It expects full settlement of most lots on 24 July.

What did Silver Mines management say?

Commenting on the strategic land acquisition helping lift the ASX All Ords silver share today, Silver Mines managing director Jo Battershill said, “Securing this strategic landholding demonstrates Silver Mines’ confidence in the future development of the Bowdens Silver Project, one of the world’s largest undeveloped silver projects.”

Battershill added:

The acquisition materially strengthens our land holding position around the project area, supporting our long-term development strategy as we progress the redetermination of the Development Consent and Mining Lease approvals.

Importantly, the acquisition delivers a number of strategic benefits to the project, including enhanced water security, biodiversity enhancement opportunities, and flexibility for future infrastructure.

The property also supports ongoing grazing and cropping activities, reflecting our commitment to responsible land stewardship and productive agricultural use.

Looking ahead, Battershill concluded:

The Bowdens Definitive Feasibility Study remains on track for completion around mid-year and we look forward to updating investors with the results in the coming months.

The post Why is this ASX All Ords silver share surging in Tuesday’s sinking market? appeared first on The Motley Fool Australia.

More reading

• Why is everyone talking about BHP shares this week?
• Guess which ASX All Ords share is rocketing 20% on big news
• Treasury Wine shares slide as another leadership change hits sentiment
• Forget term deposits! I’d buy these ASX dividend shares instead
• Buy, hold, sell: Catapult Sports, Tower, Guzman y Gomez shares

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are in the red on Tuesday as investors remain wary about whether a US-Iran deal will eventuate.

According to Trading Economics, the US and Iran are discussing a framework that would extend the ceasefire for two months.

Additionally, the US would lift its blockade of Iranian ports while Iran would reopen the Strait of Hormuz, a critical global oil and gas shipping channel.

While the world waits for further news, three experts give us their views on three ASX shares.

Let’s take a look.

Catapult Sports Ltd (ASX: CAT)

The Catapult Sports share price is $3.28, down 2.1% today and down 35% over six months.

Morgans has reiterated its buy rating on this ASX tech share and shaved its 12-month target from $5.55 to $5.40.

The broker said: 

CAT’s FY26 result confirmed strong organic momentum, with revenue US$141m (+19% c/c) and closing ACV US$134m (+28% c/c) at the top of guidance, while Management EBITDA of US$25m (17.6% margin, +67% pcp) beat MorgansF.

Operating leverage is now evident, with a 41% incremental margin (48% ex-acquisitions) in the period.

ACV per pro team crossed US$30k for the first time whilst SaaS metrics improved.

We trim FY27-FY29F Management EBITDA by 6-8% factoring in the result.

Tower Ltd (ASX: TWR)

The Tower share price is $1.58, up 1.9% today and down 6% over six months.

Mark Elzayed from Investor Pulse has a hold rating on this ASX financial share. 

On The Bull this week, Elzayed said: 

Tower is a New Zealand focused insurer benefiting from solid policy growth and improved underwriting conditions.

The company generated 15,000 new customers in the year to March 31, 2026, despite a subdued economic environment.

The company announced growth initiatives for the second half of 2026, including a partnership with Westpac Banking Corp (ASX: WBC) to offer general insurance products to its retail customers.

In our view, company performance and outlook supports a hold recommendation at this stage of the cycle.

Guzman Y Gomez Ltd (ASX: GYG)

The Guzman Y Gomez share price is $20.05, up 0.9% today and down 12% over six months.

Last week, the Mexican restaurant chain upgraded its earnings guidance and announced the abandonment of its US expansion plans.

Guzman y Gomez now expects underlying earnings before interest, taxes, depreciation, and amortisation (EBITDA) of approximately $85 million, up 29% year over year, for FY26.

Citi has reiterated its sell rating on the ASX consumer discretionary share.

The broker increased its 12-month price target from $16.55 to $18.35.

The post Buy, hold, sell: Catapult Sports, Tower, Guzman y Gomez shares appeared first on The Motley Fool Australia.

More reading

• Leading brokers name 3 ASX shares to buy today
• What is Bell Potter’s view on GYG shares after its US exit?
• How much higher could Guzman Y Gomez shares go?
• These are the 10 most shorted ASX shares
• 5 things to watch on the ASX 200 on Monday

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Catapult Sports. The Motley Fool Australia has positions in and has recommended Catapult Sports. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The S&P/ASX 200 Index (ASX: XJO) is in the red again in Tuesday morning trade, reversing some gains seen on Monday. But, here are four ASX 200 shares which I think could push the index significantly higher over the next 12 months.

Telix Pharmaceuticals Ltd (ASX: TLX)

Telix shares have tumbled 10% in May so far, but they’re still 56% higher than a multi-year low recorded in mid-February. At the time of writing on Tuesday morning, the ASX 200 biopharmaceutical stock is tumbling again, down 2.38% to $13.11 a piece.

The beaten down share price has faced several headwinds recently, including short-selling and sluggish investor sentiment. But the company is rapidly expanding into the radiopharmaceutical sector and recently announced a new FDA approval, a major collaboration, a revenue increase, and a bumper FY26 revenue guidance.

Brokers seem to think there is plenty more room for the stock to run too. They tip a 79% upside to $23.60 a piece, at the time of writing.

Zip Co Ltd (ASX: ZIP)

Zip shares have suffered a volatile start to 2026 so far. Its share price has swung anywhere between $1.45 and $3.56 a piece. At the time of writing, the shares are down another 2.22% to $2.20 each.

The tech shares have been under pressure since reaching a multi-year high in October last year. It was caught up in a tech sector-wide sell-off and investors took gains off the table after a strong rally. The ASX 200 tech shares continue to soften this month, likely due to slumping sentiment. Technology and growth shares have also come under renewed pressure again as investors reassess valuations and risk appetite.

But I think the stock is now oversold and trading far below fair value. Brokers tip a 74% upside to $3.83, at the time of writing.

Light & Wonder Inc (ASX: LNW)

Light & Wonder shares are down 0.39% to $115.79 in early morning trade on Tuesday. The tech-based gaming company’s shares surged to an all-time high in January. But the shares then crashed 44% to a three-year low of $102.66 in early May after the company posted its first quarter FY26 earnings results. The result was mixed, with a 2% increase in revenue and 5% increase in adjusted EBITDA. Meanwhile net income fell a huge 37%. Investors quickly sold up shares and while there has been a small rebound since, sentiment hasn’t yet returned.

Brokers are much more optimistic and expect a 73% upside to $198.50 over the next 12 months, at the time of writing.

Life360 Inc (ASX: 360)

Life360 shares are down another 0.74% to $18.86 at the time of writing on Tuesday morning. The latest share price is now 66% lower than an all-time high recorded in October last year.

The company has faced several headwinds, including the tech-sector-wide sell-off, a rotation away from AI-related stocks, and concerns that prices had become overvalued. But the ASX 200 company shows potential for a resurgence this year. It recently reported a 38% increase in revenue for the latest quarter, and upgraded its FY26 adjusted EBITDA and revenue guidance.

Brokers are very bullish about the outlook for Life360 shares over the next 12 months, with consensus of a strong upside ahead. They tip the shares to climb another 70% to $34.01.

The post 4 ASX 200 shares tipped to jump another 70-80% appeared first on The Motley Fool Australia.

More reading

• 2 ASX shares tipped to grow 50% in the next 12 months
• $10,000 invested in Zip shares 12 months ago is now worth…
• 2 ASX growth shares that could be long-term winners
• These are the 10 most shorted ASX shares
• These ASX 200 shares have been smashed. I think patient investors should pay attention

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Life360, Light & Wonder Inc, and Telix Pharmaceuticals. The Motley Fool Australia has positions in and has recommended Life360. The Motley Fool Australia has recommended Light & Wonder Inc and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Mineral Resources Ltd (ASX: MIN) shares are on form again on Tuesday and are pushing higher.

At the time of writing, the mining and mining services company’s shares are up 2% to a two-year high of $72.94.

Why are Mineral Resources shares hitting a new two-year high?

Investors have been bidding the company’s shares higher today after it made a big announcement relating to its lithium operations.

According to the release, the company and its joint venture partner, Jiangxi Ganfeng Lithium, have made a final investment decision (FID) to construct a flotation plant and develop underground mining at the Mt Marion lithium operation.

The release notes that the total capital investment is estimated to be $490 million on a 100% basis, invested across FY 2027 and FY 2028.

This comprises a flotation plant costing $240 million, underground pre-production development costs of $220 million, and non-processing infrastructure costs of $30 million.

Strong return on investment

The good news is that Mineral Resources expects a very quick return on investment.

It highlights that the payback period at the current spot spodumene price of approximately US$2,700 per tonne SC6 is less than one year.

The company believes the combination of a flotation plant with underground mining will support mine life by providing access to additional mineral resources below the existing open pit.

It also expects to improve plant recovery towards 70%, increase installed capacity from approximately 500,000 tonnes per year of SC6 to 600,000 tonnes per year, and remove the lower-grade SC3.5 product to deliver a single SC5 product.

Tendering for an underground mining contractor is in progress, with the central underground development expected to commence in the first quarter of FY27.

From FY 2028, Mt Marion will operate as a combined open pit and underground operation, with underground ore from open stoping supplementing up to 40% of processing feed.

The flotation circuit is an addition to the existing dense media separation plant, recovering fine spodumene currently reporting to tailings. It will be constructed and operated by the company’s Mining Services division.

Construction is targeted to commence in the first quarter of FY 2027, with commissioning and ramp-up expected in the second half of FY 2028. Minimal disruption to existing operations is expected during construction and commissioning.

Commenting on the plans, Mineral Resources’ managing director, Chris Ellison, said:

This high-return brownfield investment sets up Mt Marion for decades to come. Underground mining and flotation will work together to access deeper high-grade ore, lift recoveries and produce a single 5% product. I thank our partner Ganfeng for their collaboration on the design and commitment to these projects, which will ensure we unlock the full potential of Mt Marion.

Mineral Resources shares are now up over 200% since this time last year.

The post Mineral Resources shares hit two-year high on big lithium news appeared first on The Motley Fool Australia.

More reading

• Are these ASX shares a buy, hold or sell after hitting fresh 52-week highs?
• Here are the top 10 ASX 200 shares today
• Buy, hold, sell: Ventia, Sigma, and Mineral Resources shares
• Why Technology One, Megaport and Mineral Resources shares are turning heads on Tuesday
• Up 167% in a year, here’s why this ASX 200 lithium stock is rising again

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.